Rajić, Z.; Beus, M.; Michnová, H.; Vlainić, J.; Persoons, L.; Kosalec, I.; JampÃlek, J.; Schols, D.; Keser, T.; Zorc, B.
Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors. Molecules 2018, 23, 1724.
https://doi.org/10.3390/molecules23071724
AMA Style
Rajić Z, Beus M, Michnová H, Vlainić J, Persoons L, Kosalec I, JampÃlek J, Schols D, Keser T, Zorc B.
Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors. Molecules. 2018; 23(7):1724.
https://doi.org/10.3390/molecules23071724
Chicago/Turabian Style
Rajić, Zrinka, Maja Beus, Hana Michnová, Josipa Vlainić, Leentje Persoons, Ivan Kosalec, Josef JampÃlek, Dominique Schols, Toma Keser, and Branka Zorc.
2018. "Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors" Molecules 23, no. 7: 1724.
https://doi.org/10.3390/molecules23071724
APA Style
Rajić, Z., Beus, M., Michnová, H., Vlainić, J., Persoons, L., Kosalec, I., JampÃlek, J., Schols, D., Keser, T., & Zorc, B.
(2018). Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors. Molecules, 23(7), 1724.
https://doi.org/10.3390/molecules23071724